Article Information
History
- May 15, 2020.
Article Versions
- Version 1 (May 12, 2020 - 07:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mohammed Shabrawishi, M.D1,2,
- Manal M Al-Gethamy, M.D3,
- Abdallah Y Naser, PhD4,
- Maher A Ghazawi, M.D5,
- Ghaidaa F Alsharif, M.D2,
- Elaf F Obaid, M.D2,
- Haitham A Melebari, M.D6,
- Dhaffer M Alamri3,
- Ahmad S Brinji, M.D5,
- Fawaz H Al Jehani, M.D7,
- Wail Almaimani, M.D7,
- Rakan A Ekram, M.D8,
- Kasim H Alkhatib, M.D9 and
- Hassan Alwafi, M.D10,*
- 1Department of Respiratory Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia
- 2Department of Internal Medicine, Al Noor Specialist Hospital, Mecca, Saudi Arabia
- 3Department of Infection Prevention and Control Programme, Al Noor Specialist Hospital, Mecca, Saudi Arabia
- 4Faculty of Pharmacy, Isra University, Amman, Jordan
- 5Department of Radiology, Al Noor Specialist Hospital, Mecca, Saudi Arabia
- 6Department of Internal Medicine, King Faisal General Hospital, Mecca, Saudi Arabia
- 7Al Noor Specialist Hospital, Mecca, Saudi Arabia
- 8School of Public Health and Health Informatics, Umm Al Qura University, Mecca, Saudi Arabia
- 9Intensive Care Department, Al Noor Specialist Hospital, Mecca, Saudi Arabia
- 10Department of Clinical Pharmacology and Toxicology, Faculty of Medicine, Umm Al Qura University, Mecca, Saudi Arabia
- ↵*Corresponding author Dr.Hassan Alwafi, Department of Clinical Pharmacology and Toxicology, Umm Alqura University, Faculty of Medicine, Mecca, Saudi Arabia, Post Code 24381, T +966555544319, Email: hhwafi{at}uqu.edu.sa
Posted May 15, 2020.
“Clinical, Radiological and Therapeutic Characteristics of Patients with COVID-19 in Saudi Arabia”
